Stockscreener 앱 받기
7.36
2.65%
0.19
시장 영업 전:
7.35
-0.01
-0.14%
Ginkgo Bioworks Holdings Inc 주식(DNA)의 최신 뉴스
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
(DNA) Risk Channels and Responsive Allocation - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. (DNA) increases despite market slip: Here's what you need to know - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) stock dips while market gains: Key facts - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) insider RSU vesting triggers tax share sale - Stock Titan
EBITDA per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Revenue per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Book value per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
708 Class A shares notified for sale; prior 972-share sale (DNA) - Stock Titan
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Pre - GuruFocus
Form 144 Ginkgo Bioworks Holdings For: 16 March By Investing.com - Investing.com Canada
How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk - Yahoo Finance
Ginkgo Bioworks Posts On X "New in @sciam today: Researchers at Ginkgo and @OpenAI showed that an AI model working with an autonomous lab can design and iterate real biology experiments at unprecedented speed. From San Francisco, where GPT-5 - Benzinga
(DNA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Analysts Conflicted on These Healthcare Names: Valneva (VALN), Biogen (BIIB) and Ginkgo Bioworks Holdings (DNA) - The Globe and Mail
Ginkgo Bioworks (NYSE:DNA) Price Target Cut to $5.00 by Analysts at BTIG Research - MarketBeat
Ginkgo Bioworks (DNA): BTIG Analyst Lowers Price Target, Maintai - GuruFocus
Ginkgo Bioworks price target lowered to $5 from $9 at BTIG - TipRanks
BTIG cuts Ginkgo Bioworks stock price target on autonomous lab shift - Investing.com Canada
Ginkgo Bioworks Holdings Inc (DNA) PT Lowered to $5 at BTIG - StreetInsider
DNA (DNA) Form 144 shows director notices to sell 2,200 shares on two dates - Stock Titan
Risk Hedge: Why is Ginkgo Bioworks Holdings Inc stock going up2026 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
DNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Macro Review: Can Ginkgo Bioworks Holdings Inc expand into new marketsInsider Buying & High Win Rate Trade Alerts - baoquankhu1.vn
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen - Sahm
Ginkgo Bioworks (NYSE:DNA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Ginkgo Bioworks Bets on Autonomous Labs Amid Headwinds - The Globe and Mail
Weekly Recap: Is Ginkgo Bioworks Holdings Inc attractive for institutional investorsWall Street Watch & Momentum Based Trading Signals - baoquankhu1.vn
DNA Earnings History & Surprises | EPS & Revenue Results | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Ginkgo Bioworks Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:DNA) 2026-03-03 - Seeking Alpha
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - Insider Monkey
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure - AI Insider
Ginkgo Bioworks Launches Ginkgo Cloud Lab to Provide Remote Access for Researchers - marketscreener.com
Ginkgo Bioworks Makes Major Pivot (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks Launches Ginkgo Cloud Lab - marketscreener.com
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
A Look At Ginkgo Bioworks (DNA) Valuation As It Pivots To Robotics Labs And Biosecurity Divestiture - Sahm
DNA SEC FilingsGinkgo Bioworks Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A Look At Ginkgo Bioworks (DNA) Valuation After Earnings Update And Invaio Collaboration - Yahoo Finance
DNABW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Q4 Loss Profile Reinforces Bearish Narratives On Cash Burn And Profit Timing - Sahm
Ginkgo Bioworks Q4 Earnings Call Highlights - MarketBeat
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of Its Non-Core Biosecurity Business - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and Xenon (XENE) - The Globe and Mail
Ginkgo Bioworks Holdings Inc (DNA) Q4 2025 Earnings Call Highlights: Strategic Shifts and ... By GuruFocus - Investing.com Canada
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter - Benzinga
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business - The Malaysian Reserve
Ginkgo Bioworks Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Ginkgo Bioworks Divests Biosecurity Unit, Retains Minority Stake - TipRanks
Ginkgo Bioworks to Sell Biosecurity Unit to Tower Biosecurity, Retaining 20% Equity Stake - TradingView
Ginkgo Bioworks (NYSE: DNA) trades Biosecurity arm for 20% Tower stake - Stock Titan
Ginkgo Bioworks to sell biosecurity unit for 20% stake in Tower Biosecurity - StreetInsider
Ginkgo Bioworks Q4 2025 Earnings Call Transcript - MarketBeat
Erste Asset Management GmbH Acquires 200,000 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Releases Quarterly Earnings Results, Beats Estimates By $0.38 EPS - MarketBeat
Ginkgo Bioworks reports fourth quarter and full year 2025 financial results - marketscreener.com
1.82%
자본화:
|
볼륨(24시간):